サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390544

動物モデル市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Animal Model Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 147 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
動物モデル市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の動物モデル市場規模は、2022年に16億9,650万米ドルに達しました。今後、IMARC Groupは、市場は2028年までに25億340万米ドルに達し、2022年から2028年の間に6.70%の成長率（CAGR）を示すと予測しています。

動物モデルは、医学研究や調査に使用される生きた非ヒト種です。ヒトの遺伝学、解剖学、生理学との類似性が高いため、頻繁に選択されます。動物モデルは、ヒトに害を与えることなく、病気の予防、診断、治療に関する情報を得るのに役立ちます。一般的に利用されている動物モデルには、げっ歯類、ラット、マウス、スナネズミ、モルモット、ハムスターなどがあります。現在では、入手しやすく、取り扱いが容易で、使用コストが比較的低いことから、広く好まれています。

動物モデル市場の動向：

現在、世界中で個別化医薬品のニーズが増加し続けています。このことは、ダウン症、クローン病、乳がん、血友病などの遺伝性疾患の有病率の上昇と相まって、研究者による医薬品の前臨床開発における動物モデルの利用にプラスの影響を与えている主な要因の一つとなっています。これとは別に、動物モデルは世界中の生物医学研究、毒物学、生理学、がん研究、神経学研究、遺伝子研究、異種移植にも利用されています。さらに、この市場は、ゲノム編集技術であるCRISPR-Cas9の導入のような多くの技術的進歩によって推進されています。この技術は、広範な遺伝子改変を伴う動物モデルの作製を可能にするために必要な時間とコストの削減に役立っています。この技術は、初期分岐型から霊長類に至るまで、さまざまな動物に広く応用できます。これに加えて、伝染性コロナウイルス病（COVID-19）の突然の大流行が、市場に有利な見通しをもたらしています。これは、世界保健機関（WHO）のような国際機関や政府当局が、ワクチンや抗ウイルス薬を導入するための研究開発（R&D）活動への投資を増やしていることに起因しています。

本レポートで扱う主な質問

  • 世界の動物モデル市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界の動物モデル市場に与えた影響は？
  • 主要な地域市場は？
  • 動物の種類に基づく市場内訳は？
  • 技術別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界の動物モデル市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の動物モデル市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：動物タイプ別

  • ラット
    • 市場動向
    • 市場予測
  • マウス
    • 市場動向
    • 市場予測
  • モルモット
    • 市場動向
    • 市場予測
  • ウサギ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • CRISPR
    • 市場動向
    • 市場予測
  • 胚性幹細胞注入
    • 市場動向
    • 市場予測
  • 核移植
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 創薬・医薬品開発
    • 市場動向
    • 市場予測
  • 基礎研究
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 製薬・バイオ企業
    • 市場動向
    • 市場予測
  • 学術研究機関
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Biocytogen
    • Charles River Laboratories International Inc
    • Envigo
    • Eurofins Scientific SE
    • GenOway S.A.
    • Hera BioLabs
    • JSR Corporation
    • Ozgene Pty Ltd.
    • PerkinElmer Inc.
    • Taconic Biosciences Inc.
    • The Jackson Laboratory
    • Trans Genic Inc.
図表

List of Figures

  • Figure 1: Global: Animal Model Market: Major Drivers and Challenges
  • Figure 2: Global: Animal Model Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Animal Model Market: Breakup by Animal Type (in %), 2022
  • Figure 5: Global: Animal Model Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Animal Model Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Animal Model Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Animal Model Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Animal Model (Rat) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Animal Model (Rat) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Animal Model (Mice) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Animal Model (Mice) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Animal Model (Guinea Pigs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Animal Model (Guinea Pigs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Animal Model (Rabbits) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Animal Model (Rabbits) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Animal Model (Other Animal Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Animal Model (Other Animal Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Animal Model (CRISPR) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Animal Model (CRISPR) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Animal Model (Embryonic Stem Cell Injection) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Animal Model (Embryonic Stem Cell Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Animal Model (Nuclear Transfer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Animal Model (Nuclear Transfer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Animal Model (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Animal Model (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Animal Model (Drug Discovery and Development) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Animal Model (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Animal Model (Basic Research) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Animal Model (Basic Research) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Animal Model (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Animal Model (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Animal Model (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Animal Model (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Animal Model (Academic Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Animal Model (Academic Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Animal Model (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Animal Model (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Animal Model Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Animal Model Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Animal Model Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Animal Model Industry: SWOT Analysis
  • Figure 89: Global: Animal Model Industry: Value Chain Analysis
  • Figure 90: Global: Animal Model Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Animal Model Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Animal Model Market Forecast: Breakup by Animal Type (in Million US$), 2023-2028
  • Table 3: Global: Animal Model Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Animal Model Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Animal Model Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Animal Model Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Animal Model Market: Competitive Structure
  • Table 8: Global: Animal Model Market: Key Players
目次
Product Code: SR112023A4318

Abstract

The global animal model market size reached US$ 1,696.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,503.4 Million by 2028, exhibiting a growth rate (CAGR) of 6.70% during 2022-2028.

Animal models are living, non-human species used in medical research and investigations. They are frequently selected due to their vast similarities with the genetics, anatomy, and physiology of humans. They assist in obtaining information about the prevention, diagnosis, and treatment of diseases without causing harm to a human. Some of the commonly utilized animal models include rodents, rats, mice, gerbils, guinea pigs, and hamsters. At present, they are widely preferred on account of their availability, ease of handling, and relatively low cost of use.

Animal Model Market Trends:

Presently, there is a continuous increase in the need for personalized medicines across the globe. This, in confluence with a rising prevalence of genetic disorders, such as down syndrome, Crohn's disease, breast cancer, and hemophilia, represents one of the key factors positively influencing the utilization of animal models in the pre-clinical development of drugs by researchers. Apart from this, they are also being utilized in biomedical research, toxicology, physiology, cancer research, neurological research, genetic research, and xenotransplantation around the world. Furthermore, the market is propelled by numerous technological advancements, such as the introduction of CRISPR-Cas9, a genome editing technology, which aids in reducing the time and cost required for enabling the production of animal models with extensive genetic modifications. This technology finds wide applicability in a variety of animals, ranging from early-branching metazoans to primates. Besides this, the sudden outbreak of the contagious coronavirus disease (COVID-19) pandemic is creating a favorable outlook for the market. This can be accredited to the increasing investments by international organizations like World Health Organization (WHO) and government authorities in research and development (R&D) activities to introduce vaccines and antiviral drugs.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global animal model market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on animal type, technology, application and end user.

Breakup by Animal Type:

Rat

Mice

Guinea Pigs

Rabbits

Others

Breakup by Technology:

CRISPR

Embryonic Stem Cell Injection

Nuclear Transfer

Others

Breakup by Application:

Drug Discovery and Development

Basic Research

Others

Breakup by End User:

Pharma and Biotech Companies

Academic Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Biocytogen, Charles River Laboratories International Inc, Envigo, Eurofins Scientific SE, GenOway S.A., Hera BioLabs, JSR Corporation, Ozgene Pty Ltd., PerkinElmer Inc., Taconic Biosciences Inc., The Jackson Laboratory and Trans Genic Inc.

Key Questions Answered in This Report:

  • How has the global animal model market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global animal model market?
  • What are the key regional markets?
  • What is the breakup of the market based on the animal type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global animal model market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Animal Model Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Animal Type

  • 6.1 Rat
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Mice
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Guinea Pigs
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Rabbits
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 CRISPR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Embryonic Stem Cell Injection
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Nuclear Transfer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Drug Discovery and Development
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Basic Research
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharma and Biotech Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Biocytogen
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Charles River Laboratories International Inc
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Envigo
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Eurofins Scientific SE
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 GenOway S.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Hera BioLabs
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 JSR Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Ozgene Pty Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 PerkinElmer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Taconic Biosciences Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 The Jackson Laboratory
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Trans Genic Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis